Find Academic Supervisors

Tsung-Teh WuView profile

Professor

• Gastrointestinal Pathology
• Liver Pathology
• Esophageal Pathology
• +4 more

Dr. Tsung-Teh Wu is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic Alix School of Medicine. His clinical and research focus lies at the intersection of gastrointestinal pathology, hepatology, and molecular diagnostics. With over two decades of experience, Dr. Wu has established himself as a leading expert in the histopathological evaluation of gastrointestinal and hepatic disorders. National Taiwan University College of Medicine (BM, 1985) National Taiwan University (MS, Pathology, 1987) University of Pennsylvania (PhD, Pathology, 1991) University of Pittsburgh (Residency & Chief Residency, Pathology, 1994-1995) Johns Hopkins University (Fellowship, Gastrointestinal Pathology, 1996) Dr. Wu's research interests encompass a broad spectrum of gastrointestinal pathology, with particular expertise in celiac disease, microscopic colitis, Barrett's esophagus, hepatocellular adenomas, and various liver pathologies. His work bridges the gap between basic science and clinical practice, with numerous publications that have significantly advanced the understanding of diagnostic criteria, molecular markers, and histopathological features of gastrointestinal diseases. His recent work demonstrates a strong commitment to developing standardized diagnostic approaches and translating research findings into clinical practice. Analysis of Dr. Wu's recent publications reveals a strong focus on diagnostic criteria standardization, molecular characterization of gastrointestinal and hepatic pathologies, and development of novel diagnostic approaches. His work spans from basic histopathological studies to multicenter clinical trials, demonstrating his commitment to translating research findings into clinical practice. Key themes include molecular characterization of liver tumors, standardization of diagnostic criteria for celiac disease, and development of non-endoscopic detection methods for Barrett's esophagus. Best Paper by Pathologists-In-Training Award, Stowell-Orbison, USCAP Meeting (2004) Runner-Up Award for the Best Presentation by a Resident, Gastrointestinal Pathology Society, USCAP Meeting (2000) Award for the Best Presentation by a Resident, Gastrointestinal Pathology Society, USCAP Meeting (2000) Yeh-Su Pathology Award (1987) Dr. Wu has served in leadership roles within several professional organizations, including as President of the Washington DC Chapter of the Society of Chinese Bioscientists in America. He is an active member of the American Gastroenterological Association, American Association for Cancer Research, and the Gastrointestinal Pathology Society. His research has been supported by various institutional grants, and he serves on the Upper GI Cancer Tissue Bank Committee and the Institutional Research Grants Program at the University of Texas M.D. Anderson Cancer Center. Dr. Wu's contributions to gastrointestinal pathology continue to shape diagnostic standards and improve patient care through evidence-based pathology practices.

Lawrence J. SaubermannView profile

Professor

• Inflammatory Bowel Disease
• Gastroenterology
• Hepatology
• +4 more

Dr. Lawrence J. Saubermann is a Professor in both the Department of Medicine (Gastroenterology/Hepatology) and the Department of Pediatrics (Pediatric Gastroenterology, Hepatology and Nutrition) at the University of Rochester Medical Center. His clinical practice focuses on adolescents and adults with Inflammatory Bowel Diseases (IBD) including Crohn's Disease, Ulcerative Colitis, Celiac Sprue, and microscopic colitis, utilizing a multidisciplinary approach involving rheumatologists, pathologists, and surgeons. Education: MD from UT Southwestern Medical Center (1991) Residency: Internal Medicine, Rhode Island Hospital (1992-1994) Fellowship: Gastroenterology, Brigham & Women's Hospital (1994-1998) Research interests center on the intestinal mucosal immune system in IBD, including clinical trials with biologic agents, environmental toxin impacts, and serologic marker development. His work with the Broad Foundation, NIH, and Howard Hughes Medical Institute highlights translational research efforts. Scientific Awards: Senior Research Award (CCFA, 2003) Mentored Clinical Scientist Development Award (NIH, 1998) Fellowship (American College of Gastroenterology, 2009) Active IRB Committee Member (Panels Purple & Green, 2001-2002) Collaborations with clinical and basic science researchers, plus participation in a longitudinal IBD database study, demonstrate his integrative approach to understanding disease mechanisms and developing therapies.

• Pharmacology
• Toxicology
• Clinical Medicine
• +3 more

Michael Dall is an experienced Lecturer at the Department of Clinical Research , University of Southern Denmark , with affiliations to Karolinska Institute (KI) and Odense University Hospital (OUH). His academic work spans pharmacology, toxicology, and clinical medicine, focusing on drug safety and gastrointestinal disorders. Active in Odense University Hospital as a research unit member Contributor to Basic & Clinical Pharmacology & Toxicology Collaborator with international institutions on clinical studies In 2025, he assumed the role of Medical Director at OUH, succeeding a position left vacant after the sudden death of the previous director. His research fingerprint includes expertise in Upper Gastrointestinal Bleeding , Proton-Pump Inhibitors , and Case-Control Studies . Key publication trends include: Pharmacovigilance and drug-related adverse effects Epidemiological studies on Microscopic Colitis and NSAID use Healthcare leadership and system transformation

• Epidemiology
• Gastroenterology
• Hepatology
• +4 more

David Bergman is a Postdoctoral Researcher at the Department of Medical Epidemiology and Biostatistics , Karolinska Institutet, Sweden. He works within Jonas Ludvigsson's research group , focusing on gastrointestinal epidemiology. Doctoral thesis: Microscopic colitis: epidemiology, death and associated disorders (Karolinska, 2022) Current affiliations: Karolinska (2022-2026), Swedish healthcare system research His research spans Epidemiology , Gastroenterology , and Hepatology , with emphasis on: Population-based studies of microscopic colitis (MC) MC comorbidities: cardiovascular disease, autoimmune disorders Celiac disease and chronic liver disease associations Antibiotic impact on inflammatory bowel disease Key publication trends (2022-2025) include: MC as a risk factor for cardiovascular events Links between MC and thyroid/autoimmune diseases Swedish nationwide cohort studies using advanced biostatistics Long-term outcome analyses in digestive diseases He contributes to public outreach through Karolinska's news platform on epidemiological findings.

• Gastrointestinal Epidemiology
• Metabolic Dysfunction-Associated Steatotic Liver Disease
• Inflammatory Bowel Disease
• +4 more

Fahim Ebrahimi is a Postdoctoral Researcher at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics, working within Jonas Ludvigsson's Gastrointestinal Epidemiology research group. His research spans multiple disciplines including hepatology, gastroenterology, endocrinology, and epidemiology, with a particular focus on metabolic dysfunction-associated steatotic liver disease (MASLD), inflammatory bowel disease, and their systemic complications. His primary research interests include: Gastrointestinal epidemiology and disease patterns MASLD/NAFLD progression and complications Inflammatory bowel disease and associated conditions Cardiovascular risks in metabolic and gastrointestinal disorders Maternal-fetal health outcomes related to liver disease Dr. Ebrahimi's recent publications (2023-2025) demonstrate a strong focus on nationwide cohort studies examining the long-term consequences of MASLD, inflammatory bowel disease, and related conditions. His work frequently employs population-based methodologies to investigate connections between gastrointestinal diseases and systemic complications including cardiovascular events, cancer risk, and mortality. His research shows particular strength in multigenerational studies examining familial patterns of disease. His scientific contributions include: Multiple publications in high-impact journals including Gastroenterology, Lancet Regional Health, and Journal of Clinical Endocrinology & Metabolism Research examining bidirectional disease associations (e.g., between microscopic colitis and primary sclerosing cholangitis) Studies on the impact of MASLD across multiple organ systems Investigations into maternal-fetal health outcomes related to liver disease Dr. Ebrahimi has secured competitive research funding from the Swiss National Science Foundation and the Swiss Academy of Medical Sciences for projects including 'Characterization of Determinants of Disease Occurrence, Progression and Adverse Clinical Outcomes in Metabolic-Associated Fatty Liver Disease' and 'Effects of IL-1 Beta on the hypothalamic-pituitary-gonadal (HPG) axis in men with obesity and metabolic syndrome.'

• Inflammatory bowel disease
• Crohn's Disease
• Ulcerative Colitis
• +3 more

Dr. Rishika Chugh is an Assistant Professor of Medicine in the Division of Gastroenterology at the University of California, San Francisco (UCSF). She is board certified in internal medicine and gastroenterology, and serves as faculty at the UCSF Colitis and Crohn's Center, focusing on inflammatory bowel disease (IBD) and other gastrointestinal concerns. Education and Training: MD: Jefferson Medical College, Philadelphia, PA (2015) Internal Medicine Residency: Montefiore Medical Center, Bronx, NY Gastroenterology Fellowship: Yale New Haven Hospital, New Haven, CT (Chief Fellow in final year) Inflammatory Bowel Disease Fellowship: UCSF, San Francisco, CA Research Interests: Her work centers on IBD, including Crohn's Disease and Ulcerative Colitis, with a focus on maternal and neonatal outcomes in IBD patients, intestinal ultrasound applications, and digital health interventions. She also explores women's health and gastrointestinal imaging techniques. Key areas of expertise include: IBD drug safety and pregnancy outcomes Ultrasound in IBD diagnosis and management Clinical trials of novel therapies Medical education and entrustable professional activities Publications: Dr. Chugh's research spans IBD treatment efficacy, maternal health, and diagnostic imaging. Recent work highlights include: Immune checkpoint inhibitor-related enterocolitis management Real-world data on upadacitinib therapy Intestinal ultrasound education guidelines PIANO Registry insights on biologics in pregnancy Professional Contributions: She actively contributes to clinical care at UCSF's IBD specialty center and collaborates on national registries like PIANO. Her work bridges clinical practice with innovation in digital health and medical education.

Jonas F. LudvigssonView profile

Professor

• Epidemiology
• Gastroenterology
• Hepatology
• +6 more

Professor Jonas F. Ludvigsson is affiliated with the Karolinska Institutet as a Professor in the Department of Medical Epidemiology and Biostatistics, Örebro University Hospital as a Senior Physician in Pediatrics, and Columbia University as an Adjunct Professor. He serves as a Scientific Advisor at the Swedish National Board of Health and Welfare and Scientific Secretary of the Swedish Society of Medicine. MD, Linköping University (1995) PhD, Medicine, Linköping-Örebro (2001) Docent (Associate Professor), Örebro University Hospital (2005) Fulbright Research Scholar, Mayo Clinic (2012) His research spans gastrointestinal epidemiology , focusing on Celiac Disease , Inflammatory Bowel Disease (IBD) , and liver diseases through the ESPRESSO cohort (2.1 million individuals). He investigates the gut-brain axis , cardiovascular comorbidities , and pediatric health outcomes using Swedish National Health Registers. Recent articles reveal trends in IBD-metabolic syndrome interactions , microscopic colitis risk factors , and autism-preterm birth associations . His 2025 Solstickepriset recognized groundbreaking pediatric research. The Jubilee Prize (2022) Alvarenga Prize (2019) H.M. The King's Medal (2024) Honorary Professor at Nottingham (2015-2021) He has supervised 14 PhD students (including Professor Olén and Docents Mårild and Emilsson) and secured grants from the Swedish Heart-Lung Foundation , NICHD , and Swedish Research Council for projects on IBD-cardiovascular links, autism in preterm birth, and celiac comorbidities.

• Metabolomics
• Mental Health
• Metabolic Disorders
• +5 more

Shengxin Liu is a Postdoctoral Researcher at the Karolinska Institutet since 2023, affiliated with the Department of Medical Epidemiology and Biostatistics and Lu Yi's Precision Psychiatry research group. Funded by the Swedish Research Council, their work bridges mental and metabolic health using -omic data, particularly metabolomics, to address heterogeneity in major depressive disorder and comorbidity with diabetes. Education : PhD in Medical Epidemiology and Biostatistics (Karolinska Institutet, 2023) Research focuses on metabolic dysregulation in psychiatric subtyping, integrating epidemiological frameworks with bioinformatics for molecular and population-level insights. Their publications span diabetes, psychiatry, neurodevelopmental disorders, and perinatal immunology, emphasizing real-world healthcare applications. Key awards include the Swedish Research Council International Postdoc Grant (2023) and a grant for metabolomics research in depression (2024-2027). Supervision includes Nishan Lamichhane and Lian Meijie on psychotropic medication economics. Collaborations involve institutions like the University of Edinburgh and diabetes/endocrinology research networks.

• Computational Biology
• Bioinformatics
• Personalised Medicine
• +6 more

Leticia Camargo Tavares is a Research Fellow in Pharmacology at Monash University. Her work focuses on genomic medicine, computational biology, and personalized medicine applications in gastrointestinal disorders and cardiovascular health. She holds a PhD in Computational Biology/Genomic Medicine from Monash University (2023), an MSc in Pharmacogenetics from University of São Paulo (2019), and a Bachelor's in Physical and Biomolecular Sciences (2016). Her research integrates genomic data with clinical outcomes, particularly exploring gut microbiome-cardiovascular links and genetic determinants of gastrointestinal diseases. Notable contributions include identifying constipation as a major cardiac risk factor and discovering novel genetic associations between IBS and cardiovascular traits. Received 7 scientific awards including the 2024 APS Select Distinction and 2015 iGEM Gold Medal Collaborations span institutions in Brazil, Sweden, Netherlands, and the US Media coverage includes high-impact articles on constipation-cardiac links and IBS-genetic associations Her work aligns with UN SDG 3 (Good Health) through advancing precision medicine and disease prevention strategies.

• Gastroenterology
• Inflammatory Bowel Disease
• Crohn's Disease
• +4 more

Russell Cohen is a Professor in the Department of Medicine-Gastroenterology at the University of Chicago, where he has established himself as a leading expert in inflammatory bowel disease (IBD) with a focus on Crohn's disease and ulcerative colitis. His extensive research portfolio spans clinical investigation, therapeutic development, and patient care optimization. Dr. Cohen's primary research interests include: Inflammatory Bowel Disease pathophysiology and management Biologic therapies and biosimilars for IBD Treatment optimization for Crohn's disease and ulcerative colitis Real-world effectiveness of novel IBD therapies J-pouch surgery outcomes and complications Pharmacoeconomics of IBD treatment Pregnancy outcomes in IBD patients His recent publications (2023-2025) demonstrate continued leadership in evaluating newer biologic agents including mirikizumab and risankizumab, biosimilar medications, and the impact of healthcare system factors like prior authorization on treatment outcomes. His work on J-pouch phenotypes has refined postoperative management strategies, while research on proximal colon inflammation patterns has informed cancer surveillance approaches in high-risk patients. Dr. Cohen has collaborated extensively with colleagues at the University of Chicago and other institutions, contributing to numerous clinical studies that have shaped current IBD management practices. His work frequently appears in high-impact gastroenterology journals including Gastroenterology, Clinical Gastroenterology and Hepatology, and Inflammatory Bowel Diseases.

Jared SninskyView profile

Assistant Professor

• Inflammatory Bowel Disease
• Ulcerative Colitis
• Crohn's Disease
• +5 more

Jared Sninsky is an Assistant Professor in the Department of Medicine (Gastroenterology) at Baylor College of Medicine and a Staff Physician at the Michael E. DeBakey VA Medical Center in Houston, Texas. His educational background includes: BA from Vanderbilt University, Nashville, Tennessee MD from University of Florida College of Medicine, Gainesville, Florida Residency in Internal Medicine at Washington University in St. Louis, St. Louis, Missouri Fellowship in Gastroenterology and Hepatology at University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Advanced Fellowship in Inflammatory Bowel Disease at University of North Carolina at Chapel Hill Dr. Sninsky's research focuses on advancing personalized medicine for inflammatory bowel disease (IBD) patients, with emphasis on ulcerative colitis, Crohn's disease, and microscopic colitis. His work integrates diagnostic modeling, machine learning algorithms, and non-invasive biomarker development to optimize treatment strategies and improve clinical outcomes in gastroenterology. He maintains board certification through the American Board of Internal Medicine and American Board of Gastroenterology. Dr. Sninsky is an active member of the American Gastroenterological Association and American College of Gastroenterology, and provides clinical services in Spanish.

Richard ForsgårdView profile

Researcher

• Biomedicine
• Medicine
• Intestinal Permeability
• +7 more

Richard Forsgård is a Researcher at the School of Medical Sciences , Örebro University, affiliated with the Department of Medical Sciences and the Nutrition-Gut-Brain Interactions Research Centre (NGBI) . His work focuses on intestinal permeability , gut microbiota , and inflammation , particularly in relation to dietary fibers and chemotherapy-induced gastrointestinal toxicity. Research Interests: Forsgård investigates how stressors, drugs, and dietary interventions affect gut barrier function. His studies span gut-immune interactions , exercise-induced gastrointestinal symptoms , and microbiome adaptation . Current projects examine fermentable dietary fibers in microscopic colitis , while past work includes probiotic effects on SARS-CoV-2 immunity . Scientific Awards: Marie Curie Fellowship (2021) Publications Trends: Forsgård's research bridges biomedicine , pharmacology , and metabolomics . He employs animal models and clinical trials to explore gut health , microbiome dynamics , and nutritional interventions . His work often integrates metabolite profiling and immune marker analysis .

Julia RodeView profile

Assistant Professor

• Gut-Brain Axis
• Microbiome Research
• Neurogastroenterology
• +7 more

Julia Rode is an Assistant Professor in physiology at Örebro University's School of Medical Sciences and Department of Medical Sciences. She is affiliated with the Nutrition-Gut-Brain Interactions Research Centre (NGBI) and the Responsive Nutrition Research Centre. Her research focuses on the gut-brain axis using functional MRI and microbiome analysis. Education: BSc in Nutritional Science from Technical University of Munich MSc in Molecular Biotechnology from Technical University of Munich PhD on 'gut microbiota, its modifications and the gut-brain axis' from Örebro University (2021) Dr. Rode's research is highly interdisciplinary, focusing on the physiological processes of gut-brain interactions. She investigates how to modulate the gut-brain axis through interventions like fecal microbiota transfer and probiotics. Her work also involves finding biomarkers for psychiatric diseases, particularly ADHD. She employs functional MRI extensively to examine brain responses to various interventions and stimuli, with a special interest in how probiotics affect brain morphology and function. Her publication record shows a strong focus on the gut-brain axis, with recent work examining probiotic effects on brain function, gut microbiota composition, and the development of biomarkers for conditions like IBS and ADHD. The research spans from clinical trials to mechanistic in vitro studies, with increasing emphasis on translational applications. Scientific Awards: Best PhD Thesis Award 2021 by Nutrients ESPEN Research Fellowship 2020 Strategic research funding from Faculty of Medicine and Health at Örebro University 2023 Funding from Dr P Håkansson Foundation 2023 Pedagogical pilot project funding 2024 Dr. Rode serves as co-supervisor for two PhD students and regularly supervises Bachelor's, Master's, and Medical students. She has secured multiple research grants totaling over 1 million SEK, including projects on probiotics, gut-brain biomarkers, and developing a standardized gut-brain axis model. She is also involved in the Rosetta@ORU project as associate leader of one work package. Her teaching responsibilities span multiple programs, including the international Master's in Experimental Medicine and various health science programs. Dr. Rode leads research in the Clinical and Experimental Psychophysiology & Psychopharmacology group and the Nutrition-Gut-Brain Axis group. She collaborates nationally with researchers from Örebro University Hospital, Linnaeus University, and Karolinska Institute, and internationally with institutions in Germany, USA, and others. Her research also involves industry partnerships with companies including GSK Consumer Healthcare, Haleon, BioGaia, AnaBio, and GE.

• Gastroenterology
• Inflammatory Bowel Disease
• Medical Informatics
• +3 more

Cecilia Benoni is an Associate Professor at Lund University's Faculty of Medicine, affiliated with the Department of Anaesthesiology and Intensive Care Medicine. Her research focuses on gastrointestinal disorders, particularly microscopic colitis and related inflammatory bowel diseases. Primary Affiliation: Lund University, Faculty of Medicine Department: Anaesthesiology and Intensive Care Medicine Academic Rank: Associate Professor Benoni's work aligns with UN Sustainable Development Goals related to health and well-being (SDG3). She has published extensively on: Diagnostic biomarkers for collagenous colitis Maintenance therapies using budesonide Epidemiological patterns in chronic non-bloody diarrhea Patient experiences with chronic conditions Microbiota alterations in inflammatory bowel disease Her research output includes 23 journal articles, 1 book chapter, and 3 review materials with significant citations and clinical guideline integrations. She has mentored 2 supervised works and maintains active collaborations with international researchers.

• Gastroenterology
• Chronic Liver Diseases
• Gastrointestinal Pathology
• +3 more

Wojciech Marlicz is a Professor in the Department of Gastroenterology at Pomeranian Medical University. His research focuses on gastrointestinal diseases, microbiota interactions, and Helicobacter pylori eradication strategies. He leads the European Registry on H. pylori Management (Hp-EuReg) and contributed to COH-FIT pandemic studies. Specializes in functional GI disorders, liver pathology, and innovative diagnostic techniques like capsule endoscopy. Medical Sciences affiliation: 100% Key projects: Hp-EuReg, COH-FIT Research interests include probiotic applications, gut-brain axis, and post-COVID GI sequelae. Over 220 publications and 1 promoted thesis demonstrate his academic productivity.